Stockscreener 앱 받기
45.37
1.24%
-0.57
Moderna Inc 주식(MRNA)의 최신 뉴스
A Look At Moderna (MRNA) Valuation After Q1 2026 Earnings And New Vaccine Approvals - Yahoo Finance
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges By GuruFocus - Investing.com Canada
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges - GuruFocus
Moderna (MRNA) Reports Strong Q1 2026 Performance with $400 Million Revenue - GuruFocus
Moderna, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Legal settlement drives Q1 2026 loss at Moderna (NASDAQ: MRNA) - Stock Titan
Moderna, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales - The Economic Times
Moderna’s Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. - Barron's
Sector Update: Health Care Stocks Softer Friday Afternoon - Moomoo
Moderna, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:MRNA) 2026-05-01 - Seeking Alpha
Moderna’s first quarter 2026 sales well ahead of estimates - The Pharma Letter
RBC Capital raises Moderna stock price target on Q1 beat By Investing.com - Investing.com Canada
Biotech Stocks To Follow TodayMay 1st - MarketBeat
Moderna Reports Q1 Loss, Stock Jumps on Strong International Sales - The Globe and Mail
Moderna sees revenue bump from international COVID vaccine sales - BioPharma Dive
Moderna reports mixed Q1 results as revenue beats estimates but litigation charge weighs on earnings - Proactive financial news
[144] Moderna, Inc. SEC Filing - Stock Titan
BofA raises Moderna stock price target to $32 on Q1 beat - Investing.com India
Moderna Sales Triple To $389 Million As Shares Rise 5.4% - GuruFocus
Moderna Q1 Earnings: Revenue Beat Overshadowed By Litigation Charge, Pipeline Drives Outlook - Seeking Alpha
Why Is Moderna Stock Falling Friday?Moderna (NASDAQ:MRNA) - Benzinga
Moderna Maintains 2026 Revenue Growth Outlook as First-Quarter Results Beat Estimates - marketscreener.com
Moderna Revenue Beat: Overseas Covid Shot Sales Jump, but $900 Million Charge Clouds the Turnaround - TechStock²
Moderna beats revenue expectations with $389M, but litigation dogs earnings - BioSpace
Moderna Q1 Earnings Call Highlights - MarketBeat
Moderna tops revenue estimates on stronger international COVID vaccine sales - Yahoo! Finance Canada
Moderna Q1 2026 slides: revenue surges 260%, litigation weighs By Investing.com - Investing.com India
Transcript : Moderna, Inc., Q1 2026 Earnings Call, May 01, 2026 - marketscreener.com
Moderna Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Earnings call transcript: Moderna Q1 2026 revenue beats expectations By Investing.com - Investing.com India
Earnings call transcript: Moderna Q1 2026 revenue beats expectations - Investing.com
Moderna Q1 2026 earnings beat on international COVID vaccine sales - Yahoo Finance
Moderna Reports First Quarter 2026 Financial Results and Provides Business Updates - Investing News Network
Moderna (NASDAQ:MRNA) Beats Expectations in Strong Q1 CY2026, Stock Soars - Yahoo Finance
Moderna (MRNA) Stock Jumps 8% After Q1 Earnings Beat - CoinCentral
Moderna Up Over 6% in Pre-Market Trading - Moomoo
MRNA Stock Rises Pre-Market: Moderna Bets On US Comeback With Flu Vaccine Pipeline - Stocktwits
Moderna beats Q1 estimates and reaffirms full-year guidance - Sherwood News
Moderna (MRNA) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Moderna Inc (NASDAQ:MRNA) Surges Past Q1 Estimates on International Strength - ChartMill
Moderna : Earnings Presentation (Moderna 1Q26 Earnings Presentation FINAL) - marketscreener.com
Moderna beats revenue expectations despite wider loss - Investing.com
Moderna Q1 Loss Widens, Revenue Rises; Reiterates 2026 Revenue Outlook - marketscreener.com
Moderna stock jumps after Q1 2026 beat (MRNA:NASDAQ) - Seeking Alpha
Moderna: Q1 Earnings Snapshot - KING5.com
EU clears Moderna's flu-COVID shot as Q1 loss hits $1.3B - Stock Titan
Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimat - The Economic Times
Earnings Flash (MRNA) Moderna Posts Q1 Loss $3.40 a Share, vs. FactSet Est of $4.45 Loss - marketscreener.com
Moderna reports Q1 EPS of $ -3.40 - marketscreener.com
Moderna Reports Higher Revenue but Posts a Loss - WSJ
Earnings Flash (MRNA) Moderna, Inc. Reports Q1 Revenue $389.0M, vs. FactSet Est of $236.4M - marketscreener.com
Moderna (NASDAQ: MRNA) grows Q1 2026 revenue but books $1.3B loss - Stock Titan
Moderna’s Strong Vaccine Sales Outside US Far Surpass Estimates - Bloomberg.com
Will S&P 500 Open Up Or Down On May 1 After Best Month Since 2020? - Benzinga
Moderna (MRNA) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Moderna (MRNA) Prepares for Earnings Amid Revenue Challenges - GuruFocus
Moderna Q1 preview: revenue rebound in focus as losses persist (MRNA:NASDAQ) - Seeking Alpha
Vanguard Capital Management (MRNA) reports 25.9M-share stake (6.53%) - Stock Titan
Moderna in the spotlight: Can pipeline offset earnings decline? By Investing.com - Investing.com Australia
Moderna Inc (MRNA) Stock Price Quote Today & Current Price Chart | Capital.com UK - Capital.com
How Will Moderna Stock React To Its Upcoming Earnings? - Trefis
Moderna Stock 5-Day Losing Spree: Stock Falls 18% - Trefis
Discipline and Rules-Based Execution in MRNA Response - Stock Traders Daily
mRNA Treatment Market 2026 | Argos Therapeutics, Inc., CureVac AG, ethris GmbH, Moderna, Inc., Tiba Biotech etc. - openPR.com
Pfizer, BioNTech Defeat Moderna COVID Jab Patent - Law360
Moderna (MRNA): 10 Best Performing S&P 500 Stocks So Far in 2026 - Yahoo Finance
Leading Companies Fueling Growth and Innovation in the Spikevax Market - openPR.com
2.45%
자본화:
|
볼륨(24시간):